We are live on ! Find out more
YF

Yu Fan Portfolio holdings

AUM $97M
1-Year Est. Return 57.2%
This Fund
S&P 500
This Quarter Est. Return
+1.43%
1 Year Est. Return
+57.2%
3 Year Est. Return
-14.37%
5 Year Est. Return
-61.92%
10 Year Est. Return
AUM
$5.82M
AUM Growth
-$3.03M
Cap. Flow
-$3.09M
Cap. Flow %
-53.09%
Top 10 Hldgs %
100%
Holding
4
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
AVIR icon
Atea Pharmaceuticals
AVIR
+$3.09M

Sector Composition

Rank Sector Weight
1 Financials 83.9%
2 Healthcare 16.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ABGI
1
DELISTED
ABG Acquisition Corp. I
ABGI
$4.88M 83.9%
501,300
SYRE icon
2
Spyre Therapeutics
SYRE
$8.68B
$891K 15.31%
4,482
CRVO icon
3
CervoMed
CRVO
$24.7M
$46K 0.79%
1,198
AVIR icon
4
Atea Pharmaceuticals
AVIR
$380M
-143,867
Closed -$3.09M

Similar funds

Yu Fan's Q3 2021 Portfolio in Review

As of Q3 2021, Yu Fan held 4 positions worth $5.82M, down 34% from $8.85M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Yu Fan withdrew a net $3.09M in Q3 2021, closing 1 position. Its most notable exit was Atea Pharmaceuticals, an estimated $3.09M position sold in full.

By sector, the portfolio is most concentrated in Financials at 84% of assets, up from 56% a quarter earlier, followed by Healthcare.

  • Yu Fan fully exited Atea Pharmaceuticals in Q3 2021, selling an estimated $3.09M.
  • Yu Fan's ten largest holdings make up 100% of its $5.82M portfolio in Q3 2021.
  • Yu Fan opened 0 new positions and closed 1 in Q3 2021.
  • Yu Fan's portfolio value fell 34% quarter-over-quarter to $5.82M.

Based on Yu Fan's 13F filing for Q3 2021, filed 15 Nov 2021.